Download
drugs that affect the cardiovascular system n.
Skip this Video
Loading SlideShow in 5 Seconds..
Drugs that affect the Cardiovascular system PowerPoint Presentation
Download Presentation
Drugs that affect the Cardiovascular system

Drugs that affect the Cardiovascular system

149 Views Download Presentation
Download Presentation

Drugs that affect the Cardiovascular system

- - - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - - -
Presentation Transcript

  1. Drugs that affect the Cardiovascular system Chemeketa Community College F ’08 P. Andrews, Instructor

  2. What about ‘em?

  3. LEAD Drugs • Lidocaine • Interferes with sodium channels to block conduction abnormalities • Epinephrine • Increases heart rate, blood pressure and stimulates liver • Atropine • Blocks acetylcholine, speeds heart • Dopamine - Increases contractile force • Amiodarone • Prolongs action potential and refractory period

  4. Let’s Review First • Most drugs treat dysrhythmias • Most prevalent • Tachycardia • Bradycardia • Generated through abnormal impulse formation (automaticity) • OR abnormal conductivity

  5. Dysrhythmias - Most often caused by imbalance between sympathetic and parasympathetic nervous systems

  6. Bradycardia • Excessive parasympathetic stimulation through muscarinic receptors

  7. Tachycardia • Variety of causes • Ischemia, mycoardial infarction, excessive sympathetic stimulation

  8. Develop phase 4 depolarization, generate abnormal impulse • Ectopic foci • Abnormal conduction; • One-way valve

  9. Antidysrhythmics • SODIUM CHANNEL BLOCKERS

  10. What do they do, anyway? • -amide, ester forms of local anesthetics elevate the threshold of electric excitation of the nerve • Enter open, inactive sodium channels • Anesthetic closes the channel, blocking sodium influx • Delays impulse • Decreases action potential • Blocks conduction

  11. Lidocaine • Class • Antidysrhythmic • Indications • VT, Vf, malignant PVC’s • Action • Decreases ventricular automaticity & excitability • Raises fibrillation threshold • Decreases conduction in ischemic cardiac tissue without affecting normal conduction

  12. Contraindications • Advanced AV block (Mobitz II , 3rd degree blocks • Torsades de pointes • Stokes-Adams syndrome • Precaution: • Heart rate less than 60 • Hepatic disease - reduce by 50% • >70 y/o – reduce by 50%

  13. Side effects • Drowsiness • Dizziness • Confusion • Hypotension • Nausea, vomiting • Dysrhythmias • Respiratory depression • Cardiac arrest

  14. Route & Dosage: • Loading dose of 1 – 1.5 mg/kg IVP q 5 min. Max dose of 3 mg/kg • After perfusion is reestablished, admin. Lidocaine gtt at 2-4 mg/min (start gtt at 1 mg/min if pt > 70 y/o • How supplied • 10 mg/ml in 100 mg preload

  15. Lidocaine is drug of choice for • Most types of drug-induced monomorphic VT or Vf, and for VT, Vf associated with cocaine-induced myocardial ischemia

  16. Antidysrhythmics • Potassium Channel Blockers

  17. amiodarone (Amrinone, Cordarone) • Class • antiarrhythmic • Indications • recurrent VF, unstable VT • When other therapies are ineffective

  18. Action • Prolongs action potential and refractory period • Slows sinus rate, increases PR, QT intervals • Contraindications • Severe sinus node dysfunction • 2nd and 3rd degree AV block • Precautions • CHF, severe pulmonary or liver disease

  19. Adverse reactions • ARDS, pulmonary fibrosis, CHF, worsening of arrhythmias • Liver function abnormalities • Anorexia, constipation, N/V, ataxia, involuntary movement, paresthesia, periphreal neuropathy, tremors • Bradycardia, hypotension • Dizziness, fatigue, malaise, corneal microdeposits

  20. Route & dosage • Requires large initial loading dose (IV route) to prevent delay in onset action • Must use filter needle • Draw up slowly – Foams!

  21. For VT hemodynamically stable (SBP> 85) • 150 mg IV over 10-30 minutes • 900 mg IV over 24 hrs by infusion • Repeat 150 mg IV bolus for VT • For VT/VF unstable or no BP • 150-300 mg IV bolus • IV infusion (1mg/min) • May repeat bolus

  22. Not water soluble – must use solventPolysorbate 80 • Polysorbate 80 clinical effects: • Decrease heart rate • Depress AV node conduction • Increase atria and ventricularrefractory periods • Available only in glass ampules

  23. How supplied • 50mg/ml in 3-ml ampules

  24. Bretylium Tosylate (Bretylol) • Class; antiadysrhythmic • Different from all other antidysrhythmics • Does not suppress automaticity • Has no effect on conduction velocity

  25. Indications • VT, Vf refractory to lidocaine and defibrillation • Recurrent Vf • VT with a pulse that fails to respond to lidocaine or procainamide • Wide complex tachycardias not controlled by lidocaine and adenosine

  26. Action • Causes an initial but transient release of norepinephrine; effect lasts ~ 20 min. • Then inhibits release of norepinephrine and blocks reuptake of norepinehprine, resulting in depletion of norepinephrine. Results in: • Increased fibrillation threshold • Prolonged effective refractory period • Suppression of reentry dysrhythmias

  27. Contraindication and precautions • No contraindications when used for Tx of life-threatening dysrhythmias • Contraindicated in Torsades • Can result in prolonged hypotension in postresuscitation phase • Side effects • Initial transient elevated BP followed by hypotension • Dizziness, syncope • Angina • Bradycardia • If administered by rapid IVP, N/V

  28. Dosage • Vf, pulseless VT: 5 mg/kg IVP • Repeat with 10 mg/kg q 15 min to max dose of 30-35 mg/kg • If conversion, administer bretylium drip at 1-2 mg/min. • How supplied • 50 mg/ml in 10 ml preload

  29. Antidysrhythmics • Calcium Channel Blockers

  30. Verapamil (Isoptin, Calan) • Class • Antianginal, Antiarrhythmic, antihypertensive agent • Indications • Hypertension, angina, Prinzmetal’s angina, Af or AF with rapid ventricular response • Action • Inhibits transport of calcium into myocardial and vascular smooth muscle • Decreases SA and AV conduction

  31. Contraindications • Hypersensitivity • Precautions • Severe hepatic impairment • Adverse reactions, SE • Arrhythmias, CHF

  32. Dosage and route • 5 – 10 mg, IV • How supplied • 2.5 mg/ml in 2 & 4 ml vials, ampules and syringes

  33. diltiazem (Cardizem) • Class • Antianginal, antiarrhythmic, antihypertensive • Indication • Hypertension, angina, SVTs and Af & AF with rapid ventricular response • NEW ONSET Af/AF (onset 48 hours or less) • Diltiazem OR cardioversion • Action • Inhibits the transport of calcium into myocardial and vascular smooth muscle

  34. Contraindications • Hypersensitivity • Sick sinus syndrome • 2nd or 3rd degree AV block • Precautions • Severe hepatic impairment

  35. Adverse reactions, SE • Arrhythmias • CHF • Peripheral edema • Dosage & route • 0.25 mg/kg • May repeat in 15 minutes with dose of 0.35 mg/kg • Follow with gtt at 10 mg/hr • How supplied • 5 mg/ml in 10 ml vials • 25 mg preloads

  36. Antidysrhythmics • Miscellaneous

  37. Adenosine (Adenocard) • Class • Antiarrhythmic agent • Indication • Conversion of PSVT • As a diagnostic tool to assess myocardial perfusion

  38. Action • Restores normal sinus rhythm by interrupting re-entry pathways in AV node • Slows conduction through AV node • Contraindications • 2nd or 3rd degree block • Precautions • Asthma • Unstable angina

  39. Adverse reactions & side effects • SOB • Facial flushing • Transient arrhythmias • Dosage & route • 6 mg rapid IVP • Repeat in 1 – 2 min. prn at 12 mg rapid IVP • Repeat in 1 – 2 min. prn at 12 mg rapid IVP

  40. How supplied • 6 mg and 12 mg preload syringes or vials • Onset is immediate • Duration is 1 – 2 min • Note: Proximal IV, RAPID bolus, 20 ml flush with arm raised is critical!!

  41. digoxin (Lanoxin) • Class • Antiarrhythmic agent • Cardiotonic and inotropic agent • Indications • CHF • Tachyarrhythmias • Af & AF • PAT

  42. Action • Increases force of myocardial contractility • Prolongs refractory period of AV node • Decreases conductiion through SA and AV nodes • Contraindications • Hypersensitivity • Uncontrolled ventricular arrhythmias • AV block • IHSS

  43. Precautions • Electrolyte abnormalities • Adverse reactions, SE • Dysrhythmias • Fatigue • Blurred, yellow vision • Anorexia, N/V

  44. Dosage & route • 0.6 – 1.0 mg (10-15 mcg/kg) initially • Give additional fractions at 4 – 8 h intervals • Total dose 200 mg • How supplied • 0.25 mg/ml in 1 ml preload

  45. Magnesium Sulfate • Class: CNS depressant, anticonvulsant. • Indications • Refractory Vf/pulseless VT • Torsades de Pointes • Digoxin-induced VT/Vf • Seizures 2ndary to eclampsia

  46. Contraindications and precautions • None in refractory Vf, VT, Torsades • Renal disease • Heart block • Hypermagnesemia

  47. Side effects • Hypotension • Asystole • Cardiac arrest • Respiratory and CNS depression • Flushing • Sweating